You might know this as Long COVID. - By Dr. Ashwini Avashiti

Speciality: Infectious diseases


Speaker:

Dr. Ashwini Avashiti | MBBS, Infedis Health

Description:

A warm welcome to all the medical professionals in this interesting session on You might know this as Long COVID. - By Dr. Ashwini Avashiti.
Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), refers to a range of symptoms that persist for weeks or months after the acute phase of a COVID-19 infection has resolved. Dr. Ashwini Avashiti explains that individuals with Long COVID may experience a variety of lingering symptoms, including fatigue, shortness of breath, cognitive difficulties often termed "brain fog," chest pain, and joint or muscle pain. These symptoms can fluctuate in intensity and may impact multiple organ systems, significantly affecting the quality of life.

Dr. Avashiti notes that while the exact mechanisms behind Long COVID are not fully understood, potential causes include ongoing inflammatory responses, immune system dysregulation, and residual viral particles. The condition can affect anyone who has had COVID-19, regardless of the severity of their initial illness. Diagnosis is primarily based on patient history and symptom presentation, as there are no specific tests for Long COVID.

Management of Long COVID often involves a multidisciplinary approach, including physical therapy, cognitive rehabilitation, and symptom-specific treatments. Dr. Avashiti emphasizes the importance of personalized care and ongoing research to better understand and treat this complex condition, as well as support for patients through dedicated Long COVID clinics and support groups.
Therefore, get an overall knowledg

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

2.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

5.

Microplastics can cause malignant changes in lung cells


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot